Skip to content
Clinical Trials – home
Research site

Medical Center Artmed Ltd.

Bulgaria Ulitsa Mladost 8, 4002 Plovdiv, Bulgaria

  • 6 trials recruiting
  • Psoriatic arthropathy · Systemic lupus erythematosus · Dermatomyositis
  • Adult patients

About Specializations

Medical Center Artmed Ltd. in Plovdiv, Bulgaria specialises in clinical trials of conditions such as Psoriatic arthropathy, Systemic lupus erythematosus, Dermatomyositis, Polymyositis, and other specialisations. This site conducts important research.

Main research areas of the site

Immune System Diseases

The research at Medical Center Artmed Ltd. emphasizes autoimmune conditions such as systemic lupus erythematosus, aiming to evaluate new therapies that can lower disease activity and improve patient quality of life.

  • Evaluation of novel JAK inhibitors
  • Assessment of B‑cell targeting agents
  • Comparative studies of oral versus injectable treatments
  • Safety monitoring in chronic autoimmune therapy
  • Biomarker‑driven patient stratification

The site collaborates with regional hospitals to ensure robust trial oversight and patient safety.

Musculoskeletal Diseases

Clinical investigations include post‑menopausal osteoporosis and inflammatory muscle disorders, with a focus on improving bone density and muscle strength in affected adults.

  • Bone health endpoints using densitometry
  • Dual‑energy X‑ray absorptiometry assessments
  • Muscle strength measurement protocols
  • Evaluation of anti‑resorptive agents
  • Patient‑reported outcome integration

Participants benefit from comprehensive monitoring and access to emerging therapeutic options.

Immune System Phenomena

Investigations target core immune mechanisms, such as cytokine signaling pathways, to support the development of precision medicines for autoimmune diseases.

  • Cytokine profiling across disease stages
  • Cellular immune response analysis
  • Pathway inhibition studies
  • Immunogenicity assessment of biologics
  • Correlation of biomarkers with clinical outcomes

The program integrates laboratory expertise from European research networks.

Immune System Processes

The center explores processes like autoantibody production and complement activation to refine diagnostic tools and predict therapeutic response.

  • Autoantibody assay validation
  • Complement cascade monitoring
  • Longitudinal disease activity tracking
  • Integration of laboratory data into clinical decisions
  • Exploration of genetic risk factors

Patient involvement is guided by strict ethical standards and continuous safety oversight.

Musculoskeletal and Neural Physiological Phenomena

Research assesses muscle inflammation and neuromuscular function in idiopathic inflammatory myopathies, seeking to enhance therapeutic outcomes and functional recovery.

  • Electromyography studies
  • MRI imaging of muscle tissue
  • Functional mobility testing
  • Evaluation of fatigue scales
  • Mechanistic studies of neuro‑muscular interaction

Located in Plovdiv, Bulgaria, the site provides a multidisciplinary environment for innovative trial conduct.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Ulitsa Mladost 84002 PlovdivBulgaria
Recruiting now
6 trials
Conditions studied
13

More sites in PlovdivBulgaria

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

30 clinical trials

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Zasocitinib
  • Sponsor:Takeda Development Center Americas Inc.
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Apremilast
  • Sponsor:Takeda Development Center Americas Inc.
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Litifilimab
  • Sponsor:Biogen Idec Research Limited
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Azathioprine
  • Sponsor:Pfizer Inc.

Dermatomyositis+1

Recruiting
Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Azathioprine
  • Sponsor:Pfizer Inc.
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Sonelokimab
  • Sponsor:MoonLake Immunotherapeutics AG
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Ascorbic Acid
  • Sponsor:Curateq Biologics Private Limited
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Octapharma Pharmazeutika Produktionsgesellschaft mbH

Sjogren's syndrome

Not recruiting
Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Nipocalimab
  • Sponsor:Janssen - Cilag International

Rheumatoid arthritis

Not recruiting
Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:IMEROPRUBART
  • Sponsor:Immunovant Sciences GmbH
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.